Programme Day 3

• Implementing IPC- Centered SSI Prevention Programs: Local Approaches That Work
• Decolonisation and Gut Decontamination Using Bacteriophages
• Antimicrobial Prophylaxis in Surgery: IPC Implications in the Age of Resistance
• Q&A

• From Surveillance to Stewardship: Harnessing ACORN-HAI for Regional Infection Control Impact
• Trials That Matter: Designing Pragmatic Studies for Drug-Resistant Infections in LMIC Settings
• Strengthening IPC with Genomics: Lessons from Regional AMR Surveillance
• Q&A

• Strategies to Prevent CAUTI in the MDR era
• Diagnostic Stewardship in CAUTI: Is It Really CAUTI?
• Using A Multimodal Approach to Improve Practice
• Q&A

• Promoting a Safety Culture in Healthcare Settings
• Personalising Patient Management and IPC
• Establishing Effective Communication in MDRO
• Q&A

• Candida Auris : An Emerging IPC threat
• Management of Outbreaks of Fungal Infection in Hospitals
• Q&A

• Reimagining Dental infection prevention in a post Pandemic World
• Next-Generation Infection Surveillance: AI, Big Data, and Beyond
• Leveraging Technology and Leadership to Advance Patient Safety and Engage IP Workforce
• Q&A

• Healthcare Associated TB: Protecting Healthcare Workers
• Ventilator Associated Events: the Surveillance and Progress for Prevention
• Room Ventilation in Managing Patients with Transmissable Respiratory Pathogens
• Q&A

• National Point Prevalence Surveys - Challenges and Uses
• WHO's Guideline Update on HAI Surveillance - They Why's and Hows
• PPS Surveillance in Australia: Aligning PPS with National IPC and AMS Goals
• Q&A